A biomimetic theranostic O2-meter for cancer targeted photodynamic therapy and phosphorescence imaging
- PMID: 29040939
- DOI: 10.1016/j.biomaterials.2017.10.021
A biomimetic theranostic O2-meter for cancer targeted photodynamic therapy and phosphorescence imaging
Abstract
In this report, a biomimetic theranostic oxygen (O2)-meter (cancer cell membrane@Pt(II) porphyrinic-metal organic framework, designated as mPPt) was constructed for cancer targeted and phosphorescence image-guided photodynamic therapy (PDT). mPPt presents high photosensitizers (PSs) loading and evitable self-quenching behaviors for favorable biological O2 sensing and PDT. Besides, endowed by the surface functionalization of cancer cell membrane, the homotypic targeting and immune escape abilities of mPPt could dramatically enhance its cancer targeting ability. Importantly, the O2-dependent phosphorescence responsibility of mPPt could be employed to pre-evaluate the real time O2 level in situ and guide the PDT under light irradiation. A significant anticancer effect is observed after intravenous injection of mPPt and subsequent treatment with PDT with no obvious side effects. As a versatile platform for cell imaging, O2 fluctuation monitoring as well as PDT, this biomimetic O2-meter exhibits great potential for biological analysis and personalized cancer theranostics.
Keywords: Homologous targeting; Hypoxia imaging; Photodynamic therapy; Porphyrinic metal organic framework; Theranostic.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
Defect-engineered porphyrinic metal-organic framework nanoparticles for targeted multimodal cancer phototheranostics.Chem Commun (Camb). 2021 Apr 22;57(33):4035-4038. doi: 10.1039/d0cc07903k. Chem Commun (Camb). 2021. PMID: 33885676
-
Cancer Cell Membrane Camouflaged Cascade Bioreactor for Cancer Targeted Starvation and Photodynamic Therapy.ACS Nano. 2017 Jul 25;11(7):7006-7018. doi: 10.1021/acsnano.7b02533. Epub 2017 Jul 5. ACS Nano. 2017. PMID: 28665106
-
Hemoglobin-mediated biomimetic synthesis of paramagnetic O2-evolving theranostic nanoprobes for MR imaging-guided enhanced photodynamic therapy of tumor.Theranostics. 2020 Sep 19;10(25):11607-11621. doi: 10.7150/thno.46228. eCollection 2020. Theranostics. 2020. PMID: 33052236 Free PMC article.
-
Porphyrins and related macrocycles: Combining photosensitization with radio- or optical-imaging for next generation theranostic agents.Photodiagnosis Photodyn Ther. 2018 Sep;23:281-294. doi: 10.1016/j.pdpdt.2018.06.023. Epub 2018 Jul 29. Photodiagnosis Photodyn Ther. 2018. PMID: 30009949 Review.
-
Photosensitizers for Photodynamic Therapy.Adv Healthc Mater. 2019 Jul;8(13):e1900132. doi: 10.1002/adhm.201900132. Epub 2019 May 8. Adv Healthc Mater. 2019. PMID: 31067008 Review.
Cited by
-
A Theranostic Nanoprobe for Hypoxia Imaging and Photodynamic Tumor Therapy.Front Chem. 2019 Dec 20;7:868. doi: 10.3389/fchem.2019.00868. eCollection 2019. Front Chem. 2019. PMID: 31921785 Free PMC article.
-
Biomimetic Nanotechnology toward Personalized Vaccines.Adv Mater. 2020 Apr;32(13):e1901255. doi: 10.1002/adma.201901255. Epub 2019 Jun 17. Adv Mater. 2020. PMID: 31206841 Free PMC article. Review.
-
Cell Membrane Coating Nanotechnology.Adv Mater. 2018 Jun;30(23):e1706759. doi: 10.1002/adma.201706759. Epub 2018 Mar 27. Adv Mater. 2018. PMID: 29582476 Free PMC article. Review.
-
Carrier-free nanodrugs with efficient drug delivery and release for cancer therapy: From intrinsic physicochemical properties to external modification.Bioact Mater. 2021 Jul 6;8:220-240. doi: 10.1016/j.bioactmat.2021.06.035. eCollection 2022 Feb. Bioact Mater. 2021. PMID: 34541398 Free PMC article. Review.
-
Photoactive and Luminescent Transition Metal Complexes as Anticancer Agents: A Guiding Light in the Search for New and Improved Cancer Treatments.Biomedicines. 2022 Mar 1;10(3):578. doi: 10.3390/biomedicines10030578. Biomedicines. 2022. PMID: 35327379 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials